ImmunoGen Shares Outstanding 2006-2019 | IMGN

ImmunoGen shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ImmunoGen Annual Shares Outstanding
(Millions of Shares)
2018 140
2017 98
2016 0
2016 87
2015 86
2014 85
2013 84
2012 77
2011 69
2010 59
2009 51
2008 43
2007 42
2006 41
2005 41
ImmunoGen Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 148
Q4 2018 140
Q3 2018 147
Q2 2018 134
Q1 2018 131
Q4 2017 98
Q3 2017 93
Q2 2017 87
Q1 2017 87
Q4 2016 0
Q3 2016 87
Q2 2016 87
Q1 2016 87
Q4 2015 87
Q3 2015 87
Q2 2015 0
Q1 2015 86
Q4 2014 87
Q3 2014 86
Q2 2014 0
Q1 2014 86
Q4 2013 87
Q3 2013 85
Q2 2013 0
Q1 2013 84
Q4 2012 84
Q3 2012 83
Q2 2012 0
Q1 2012 77
Q4 2011 77
Q3 2011 76
Q2 2011 0
Q1 2011 68
Q4 2010 68
Q3 2010 68
Q2 2010 0
Q1 2010 57
Q4 2009 57
Q3 2009 57
Q2 2009 0
Q1 2009 51
Q4 2008 51
Q3 2008 51
Q2 2008 0
Q1 2008 43
Q4 2007 43
Q3 2007 42
Q2 2007 0
Q1 2007 42
Q4 2006 42
Q3 2006 41
Q2 2006 0
Q1 2006 41
Q4 2005 41
Q3 2005 41
Q2 2005 0
Q1 2005 41
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.293B $0.054B
ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.031B 34.52
Takeda Pharmaceutical (TAK) Japan $27.263B 8.00
Grifols (GRFS) Spain $13.758B 17.40
Sage Therapeutics (SAGE) United States $9.342B 0.00
Ionis Pharmaceuticals (IONS) United States $9.027B 19.73
Neurocrine Biosciences (NBIX) United States $7.759B 0.00
Catalent (CTLT) United States $7.758B 31.14
Jazz Pharmaceuticals (JAZZ) Ireland $7.610B 10.43
Nektar Therapeutics (NKTR) United States $6.076B 9.90
Tilray (TLRY) Canada $4.905B 0.00
FibroGen (FGEN) United States $3.817B 0.00
United Therapeutics (UTHR) United States $3.396B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.362B 11.80
Arrowhead Pharmaceuticals (ARWR) United States $2.666B 401.71
PTC Therapeutics (PTCT) United States $2.551B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.061B 7.42
Xencor (XNCR) United States $1.981B 54.09
Portola Pharmaceuticals (PTLA) United States $1.867B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.816B 87.96
Zogenix (ZGNX) United States $1.724B 0.00
USANA Health Sciences (USNA) United States $1.703B 14.80
Enanta Pharmaceuticals (ENTA) United States $1.702B 23.26
Ironwood Pharmaceuticals (IRWD) United States $1.693B 0.00
Tricida (TCDA) United States $1.689B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.617B 0.00
Heron Therapeutics (HRTX) United States $1.464B 0.00
Aerie Pharmaceuticals (AERI) United States $1.419B 0.00
Esperion Therapeutics (ESPR) United States $1.360B 0.00
Turning Point Therapeutics (TPTX) United States $1.326B 0.00
Corcept Therapeutics (CORT) United States $1.203B 17.16
ArQule (ARQL) United States $1.147B 0.00
Radius Health (RDUS) United States $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.930B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.921B 0.00
Endo (ENDP) Ireland $0.869B 1.40
Odonate Therapeutics (ODT) United States $0.756B 0.00
Aptorum Group (APM) China $0.743B 0.00
CannTrust Holdings (CTST) Canada $0.695B 0.00
Organogenesis Holdings (ORGO) United States $0.652B 0.00
Translate Bio (TBIO) United States $0.639B 0.00
TherapeuticsMD (TXMD) United States $0.639B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.566B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Dermira (DERM) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.521B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
GlycoMimetics (GLYC) United States $0.480B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Siga Technologies (SIGA) United States $0.448B 1.06
Flexion Therapeutics (FLXN) United States $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.426B 21.48
Collegium Pharmaceutical (COLL) United States $0.416B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.407B 0.00
Karyopharm Therapeutics (KPTI) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 0.00
KalVista Pharmaceuticals (KALV) United States $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.368B 0.00
TCR2 Therapeutics (TCRR) United States $0.368B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.358B 0.00
Forty Seven (FTSV) United States $0.332B 0.00
OptiNose (OPTN) United States $0.324B 0.00
Harpoon Therapeutics (HARP) United States $0.314B 0.00
Molecular Templates (MTEM) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Xeris Pharmaceuticals (XERS) United States $0.299B 0.00
Concert Pharmaceuticals (CNCE) United States $0.260B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.247B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.244B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.228B 2.21
Recro Pharma (REPH) United States $0.224B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.210B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.204B 0.00
Ocular Therapeutix (OCUL) United States $0.189B 0.00
Aclaris Therapeutics (ACRS) United States $0.187B 0.00
Galectin Therapeutics (GALT) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Opexa Therapeutics (ACER) United States $0.185B 0.00
MEI Pharma (MEIP) United States $0.176B 0.00
Bio Blast Pharma (ENLV) Israel $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 55.31
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.167B 0.00
Minerva Neurosciences (NERV) United States $0.165B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
IMV INC (IMV) Canada $0.158B 0.00
Jounce Therapeutics (JNCE) United States $0.158B 0.00
Redhill Biopharma (RDHL) Israel $0.149B 0.00
Calithera Biosciences (CALA) United States $0.147B 0.00
Majesco Entertainment (PTE) United States $0.146B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.144B 0.00
Neon Therapeutics (NTGN) United States $0.128B 0.00
Tyme Technologies (TYME) United States $0.114B 0.00
Avenue Therapeutics (ATXI) United States $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.103B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.102B 0.00
DURECT (DRRX) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 70.00
China SXT Pharmaceuticals (SXTC) China $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.094B 0.00
Cardiome Pharma (CORV) Canada $0.091B 0.00
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Natural Alternatives (NAII) United States $0.089B 8.86
Capnia (SLNO) United States $0.088B 0.00
Nivalis Therapeutics (ALPN) United States $0.082B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
Novan (NOVN) United States $0.067B 0.00
ElectroCore (ECOR) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.059B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Zafgen (ZFGN) United States $0.050B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.048B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.038B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
GTx (ONCT) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Pain Therapeutics (SAVA) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.64
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.016B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Shineco (TYHT) China $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 1.74
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00